Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the period from February 1 to February 28, 2022. The report details consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and Fiscal Council, in compliance with Article 11 of CVM Instruction # 358/2002. The filing was signed on March 9, 2022.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It strictly reports on insider trading activity.
| Group | Transaction Type | Security | Quantity | Price (R$) | Volume (R$) |
|---|---|---|---|---|---|
| Board of Directors | Sell | ADR Common | 221,139 | 15.073916 | 3,333,430.71 |
| Management | None | N/A | 0 | N/A | 0 |
| Fiscal Council | None | N/A | 0 | N/A | 0 |
Material Changes
During the reporting period, the Board of Directors reduced their aggregate holding of American Depositary Receipts (ADRs). The initial balance of ADRs held by the Board was 1,136,139, and the final balance was 915,000 following the sale of 221,139 shares. There were no changes in the holdings of Common Shares for the Board, nor were there any transactions reported for Management or the Fiscal Council.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is limited to the disclosure of specific securities transactions.
Investor Verification Checklist
- Verify the total volume of the Board of Directors' sale (R$ 3,333,430.71) against market data for February 25, 2022.
- Confirm the final ADR balance for the Board of Directors (915,000) in subsequent filings.
- Note that no transactions were reported for Management or the Fiscal Council during this period.
- Recognize that this filing contains no operational or financial performance metrics for Ambev S.A.